Morning Overview on MSN
Adding one experimental drug left twice as many pancreatic-cancer patients alive after a year
Patients diagnosed with metastatic pancreatic cancer face some of the bleakest odds in oncology, with most surviving less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results